BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7262797)

  • 21. Hodgkin's disease of the oesophagus: a literature review.
    Jones K; Pacella J; Wasty F
    Australas Radiol; 2007 Oct; 51(5):489-91. PubMed ID: 17803804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Hodgkin's disease. Five years' experience of a combined haemic-lymphatic clinic.
    Ewing DP; Rozenberg MC; Freedman A; Grace CS; Lam-Po-Tang PR
    Med J Aust; 1974 Jul; 2(4):128-32. PubMed ID: 4419384
    [No Abstract]   [Full Text] [Related]  

  • 23. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
    J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hodgkin's lymphoma: problems in the treatment of the early stages].
    Bacigalupo A; Barra S; Corvò R; Guenzi M; Scolaro T; Vitale V
    Radiol Med; 1996 Nov; 92(5):620-3. PubMed ID: 9036456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Hodgkin's disease.
    Meyer SA; Thar T
    Am Fam Physician; 1981 Nov; 24(5):217-21. PubMed ID: 7293915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical aspects and primary therapy of Hodgkin's lymphomas].
    Sieber M; Tesch H; Diehl V
    Praxis (Bern 1994); 1996 Mar; 85(12):364-70. PubMed ID: 8643899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of combined treatment in management of Hodgkin's disease.
    Patrício MB; Vilhena M; de Ponte MA; Cabral R; Simões MJ; Branco F; Ricardo JA
    Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1016-22. PubMed ID: 7130791
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mediastinal involvement in Hodgkin's disease. Prognosis and therapeutic implications].
    Tawil E; Mercier JP; Ehramdjian V
    Union Med Can; 1983 Jul; 112(7):611-2, 617-8. PubMed ID: 6636350
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy.
    Behrendt H; Brinkhuis M; Van Leeuwen EF
    Med Pediatr Oncol; 1996 Apr; 26(4):244-8. PubMed ID: 8600335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late relapse after treatment for clinical stage I and II Hodgkin's disease.
    Brierley JD; Rathmell AJ; Gospodarowicz MK; Sutcliffe SB; Pintillie M
    Cancer; 1997 Apr; 79(7):1422-7. PubMed ID: 9083165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The story about Hodgkin's lymphoma].
    Ostojić Kolonić S
    Acta Med Croatica; 2008 Oct; 62(4):409-12. PubMed ID: 19205418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
    Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors and treatment of advanced Hodgkin's disease].
    Fermé C
    Rev Prat; 1998 May; 48(10):1082-6. PubMed ID: 9781152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.